We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$184B
AUM Growth
+$19.3B
Cap. Flow
+$14.4B
Cap. Flow %
7.84%
Top 10 Hldgs %
28.75%
Holding
9,312
New
1,386
Increased
3,407
Reduced
3,196
Closed
1,107

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$657M
2
AVGO icon
Broadcom
AVGO
+$562M
3
GS icon
Goldman Sachs
GS
+$549M
4
MSFT icon
Microsoft
MSFT
+$418M
5
RTX icon
RTX Corp
RTX
+$345M

Sector Composition

Rank Sector Weight
1 Technology 5.07%
2 Financials 4.87%
3 Industrials 4.29%
4 Consumer Discretionary 3.64%
5 Healthcare 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRN
7976
Western Copper and Gold
WRN
$541M
$15K ﹤0.01%
+18,919
New +$17K
CSCI
7977
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$15K ﹤0.01%
103
-65
-39% -$12.7K
CSCI
7978
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$15K ﹤0.01%
+102
New +$20K
FTEK icon
7979
Fuel Tech
FTEK
$45.3M
$14K ﹤0.01%
11,258
-15,768
-58% -$18.4K
HURA
7980
TuHURA Biosciences
HURA
$146M
$14K ﹤0.01%
+1
New +$21.9K
TBCH
7981
Turtle Beach Corp
TBCH
$230M
$14K ﹤0.01%
5,726
-3,086
-35% -$6.02K
EPE
7982
CALL
DELISTED
EP Energy Corporation
EPE
$14K ﹤0.01%
10,400
-11,300
-52% -$21.8K
ANTH
7983
PUT
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$14K ﹤0.01%
+43,700
New +$65.2K
JRJR
7984
DELISTED
JRjr33, Inc.
JRJR
$14K ﹤0.01%
108,867
+57,739
+113% +$9.34K
BGI icon
7985
Birks Group
BGI
$6.5M
$13K ﹤0.01%
+12,219
New +$15.5K
CXRX
7986
DELISTED
Concordia International Corp. Common Stock
CXRX
$13K ﹤0.01%
+27,618
New +$18.2K
VVUS
7987
CALL
DELISTED
Vivus Inc
VVUS
$13K ﹤0.01%
3,620
-730
-17% -$3.38K
YDKG
7988
CALL
Yueda Digital Holding
YDKG
$5.81M
$12K ﹤0.01%
7
-2
-22% -$4.44K
BDRX
7989
Biodexa Pharmaceuticals
BDRX
$1.61M
0
BDR
7990
DELISTED
Blonder Tongue Laboratories Inc
BDR
$12K ﹤0.01%
16,405
-23,413
-59% -$15K
GST
7991
CALL
DELISTED
Gastar Exploration Inc.
GST
$12K ﹤0.01%
17,900
-3,300
-16% -$3.08K
GST
7992
DELISTED
Gastar Exploration Inc.
GST
$12K ﹤0.01%
18,199
-104,760
-85% -$97.7K
BXE
7993
DELISTED
Bellatrix Exploration Ltd.
BXE
$12K ﹤0.01%
10,781
-15,262
-59% -$19.9K
CELGZ
7994
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$12K ﹤0.01%
+32,480
New +$21.3K
BLRX
7995
BioLineRX
BLRX
$11.8M
$11K ﹤0.01%
22
-14
-39% -$8.58K
UAMY icon
7996
United States Antimony
UAMY
$799M
$11K ﹤0.01%
44,287
-45,404
-51% -$13.5K
XTIA icon
7997
XTI Aerospace
XTIA
$60.4M
0
VIVS
7998
PUT
VivoSim Labs
VIVS
$1.15M
$11K ﹤0.01%
44
-140
-76% -$40.8K
TRNX
7999
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$11K ﹤0.01%
+117
New +$25K
ANTH
8000
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$11K ﹤0.01%
+35,297
New +$52.7K

Similar funds

Citadel Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Citadel Advisors held 9,312 positions worth $184B, up 12% from $164B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $14.4B of net new capital in Q1 2018, opening 1,386 new positions and adding to 3,407 existing holdings. Its largest new stake was Coterra Energy: 3,637,165 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 6.1% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Comcast, an estimated $764M trimmed.

  • Citadel Advisors's largest Q1 2018 buy was Coterra Energy: 3,637,165 shares worth $87.2M.
  • Citadel Advisors added most to NXP Semiconductors in Q1 2018, an estimated $657M increase.
  • Citadel Advisors's biggest Q1 2018 reduction was Comcast, cutting an estimated $764M.
  • Citadel Advisors fully exited MSC Industrial Direct in Q1 2018, selling an estimated $118M.
  • Citadel Advisors's ten largest holdings make up 29% of its $184B portfolio in Q1 2018.
  • Citadel Advisors opened 1,386 new positions and closed 1,107 in Q1 2018.
  • Citadel Advisors's portfolio value rose 12% quarter-over-quarter to $184B.

Based on Citadel Advisors's 13F filing for Q1 2018, filed 11 May 2018.